Multidisciplinary Aftercare for Elderly with STROke (MAESTRO).

MAESTRO: the effects of a multidisciplinary care programme for elderly persons with stroke who are admitted to a nursing home for rehabilitation and return home after discharge.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON23020

Enrollment

256

Registered

2010-07-12

Start date

2010-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, aftercare, social participation, quality of life CVA, nazorg, participatie, kwaliteit van leven

Interventions

The transmural integrated care programme consists of three care modules

1. Working on recovery and learning to deal with impairments

2. Self-management after stroke

3. Education programme for patients and carers. The main goal of the programme is to give optimal support and treatment to as well the patients as the carers. This will be provided in the nursing hom

Eligibility

Inclusion criteria

Inclusion criteria: 1. Admitted to a stroke-unit in a nursing home; 2. 65 years or older; 3. Community-dwelling before admission to the nursing home.

Exclusion criteria

Exclusion criteria: Patients who are incapacitated.

Design outcomes

Primary

Measure	Time frame
Primairy outcome measures of the patients: 1. Ability to live independently will be measured with the dutch version of the Frenchay Activity Index, the MODI-FAI; 2. Functional status will be measured with the Katz-15 questionnaire; 3. Perceived quality of life (disease specific) will be measured with the Stroke Specific Quality of Life Measure; 4. Social participation will be measured with the ‘Impact on participation en autonomy (IPA)’. Pimairy outocme measures of the informal caregivers: 1. Objective care burden will be measured with the Erasmus iBMG meetinstrument; 2. Perceived care burden will be measured with the Self-Rated Burden Vas en Carer Quality of life questionnaire.	—

Measure

Time frame

Primairy outcome measures of the patients: 1. Ability to live independently will be measured with the dutch version of the Frenchay Activity Index, the MODI-FAI; 2. Functional status will be measured with the Katz-15 questionnaire; 3. Perceived quality of life (disease specific) will be measured with the Stroke Specific Quality of Life Measure; 4. Social participation will be measured with the ‘Impact on participation en autonomy (IPA)’. Pimairy outocme measures of the informal caregivers: 1. Objective care burden will be measured with the Erasmus iBMG meetinstrument; 2. Perceived care burden will be measured with the Self-Rated Burden Vas en Carer Quality of life questionnaire.

—

Secondary

Measure	Time frame
Secondary outcome measures of the patients: 1. Perceived health will be measured with the RAND-36; 2. Perceived quality of life (general) will be measured with the RAND-36, a grade for the current life (Cantril’s Self Anchoring Ladder); 3. Psychological wellbeing will be measured with the RAND-36; 4. Social functioning will be measured with the RAND-36. Secondary outcome measures of the informal caregivers: 1. Percieved quality of life wll be measured with the RAND-36 and a grade for the current life (Cantril’s Self Anchoring Ladder); 2. Perceived health will be measured with the RAND-36.	—

Measure

Time frame

Secondary outcome measures of the patients: 1. Perceived health will be measured with the RAND-36; 2. Perceived quality of life (general) will be measured with the RAND-36, a grade for the current life (Cantril’s Self Anchoring Ladder); 3. Psychological wellbeing will be measured with the RAND-36; 4. Social functioning will be measured with the RAND-36. Secondary outcome measures of the informal caregivers: 1. Percieved quality of life wll be measured with the RAND-36 and a grade for the current life (Cantril’s Self Anchoring Ladder); 2. Perceived health will be measured with the RAND-36.

—

Contacts

Public ContactTom Vluggen

Universiteitssingel 40

t.vluggen@zw.unimaas.nl+31 (0)43 3881730

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)